Infinity Pharmaceuticals Inc (NASDAQ:INFI)

Data as of Jan 30
 +0.22 / +1.45%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Infinity Pharmaceuticals, Inc. is an innovative drug discovery and development company, which engages in discovering, developing and delivering medicines for difficult-to-treat diseases, developing novel small molecule drugs that target emerging disease pathways. Its programs focus on the inhibition of phosphoinositide-3-kinase, heat shock protein and fatty acid amide hydrolase. Infinity Pharmaceuticals was founded on March 22, 1995 and is headquartered in Cambridge, MA.

Contact Information

Infinity Pharmaceuticals, Inc.
780 Memorial Drive
Cambridge Massachusetts 02139
P:(617) 453-1000
Investor Relations:
(617) 453-1336



Other institutional48.51%
Mutual fund holders47.80%
Individual stakeholders20.40%

Top Executives

Adelene Q. PerkinsChairman, President & Chief Executive Officer
Lawrence E. BlochCFO, Secretary, Treasurer & CAO
John J. KeiltyVP-Information Technology & Informatics
Vito J. PalombellaChief Scientific Officer
Julian AdamsPresident-Research & Development

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.